Letong ChemicalLTD Valuation
Is 2319 undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
0/6Valuation Score 0/6
Below Fair Value
Significantly Below Fair Value
Price-To-Sales vs Peers
Price-To-Sales vs Industry
Price-To-Sales vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of 2319 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: 002319 (CN¥12.08) is trading above our estimate of fair value (CN¥4.74)
Significantly Below Fair Value: 002319 is trading above our estimate of fair value.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for 2319?
Other financial metrics that can be useful for relative valuation.
What is 2319's n/a Ratio? | |
---|---|
n/a | 0x |
n/a | n/a |
Market Cap | CN¥2.42b |
Key Statistics | |
---|---|
Enterprise Value/Revenue | 6.7x |
Enterprise Value/EBITDA | 89.4x |
PEG Ratio | n/a |
Price to Sales Ratio vs Peers
How does 2319's PS Ratio compare to its peers?
Company | Forward PS | Estimated Growth | Market Cap |
---|---|---|---|
Peer Average | 1.2x | ||
300340 Jiangmen Kanhoo Industry | 0.9x | n/a | CN¥2.3b |
002136 Anhui Annada Titanium Industry | 1.2x | n/a | CN¥2.4b |
603683 Shanghai Smith Adhesive New MaterialLtd | 1.6x | n/a | CN¥2.7b |
605488 Zhejiang Fulai New MaterialLtd | 1.2x | n/a | CN¥2.6b |
002319 Letong ChemicalLTD | 6.2x | n/a | CN¥2.4b |
Price-To-Sales vs Peers: 002319 is expensive based on its Price-To-Sales Ratio (6.2x) compared to the peer average (1.2x).
Price to Earnings Ratio vs Industry
How does 2319's PE Ratio compare vs other companies in the CN Chemicals Industry?
Price-To-Sales vs Industry: 002319 is expensive based on its Price-To-Sales Ratio (6.2x) compared to the CN Chemicals industry average (2.2x).
Price to Sales Ratio vs Fair Ratio
What is 2319's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
Fair Ratio | |
---|---|
Current PS Ratio | 6.2x |
Fair PS Ratio | n/a |
Price-To-Sales vs Fair Ratio: Insufficient data to calculate 002319's Price-To-Sales Fair Ratio for valuation analysis.
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Analyst Forecast: Insufficient data to show price forecast.